
OXY · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $21.57B | $22.71B | $23.23B | $36.23B | $25.96B | $17.13B | $19.19B | $15.56B |
| Cost of Revenue | — | $3.12B | $3.12B | $3.27B | $2.77B | $2.41B | $2.79B | $2.83B |
| Selling, General & Administrative | $986.00M | $960.00M | $987.00M | $945.00M | $863.00M | $864.00M | $893.00M | $585.00M |
| Other Income / (Expense) | $76.00M | $759.00M | $426.00M | $1.11B | $753.00M | -$53.00M | $606.00M | $331.00M |
| Income Before Taxes | $3.13B | $4.02B | $4.66B | $14.12B | $3.71B | -$15.71B | $354.00M | $5.61B |
| Provision for Income Taxes | $1.02B | $1.16B | $1.33B | $813.00M | $915.00M | -$2.17B | $861.00M | $1.48B |
| Net Income | $2.37B | $3.08B | $4.70B | $13.30B | $2.32B | -$14.83B | -$985.00M | $4.13B |
| Basic EPS | $1.65 | $2.59 | $4.22 | $13.41 | $1.62 | -$17.06 | -$1.22 | $5.40 |
| Diluted EPS | $1.61 | $2.44 | $3.90 | $12.40 | $1.58 | -$17.06 | -$1.22 | $5.39 |
| Basic Shares Outstanding | 975.50M | 911.80M | 889.20M | 926.20M | 935.00M | 918.70M | 809.50M | 761.70M |
| Diluted Shares Outstanding | 1.00B | 967.10M | 960.90M | 1.00B | 958.80M | 918.70M | 809.50M | 763.30M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $6.20 | $5.10 | $8.22 | 9 | ↑4 ↓0 |
| Dec 2027 | $4.21 | $2.80 | $7.94 | 11 | ↑2 ↓2 |
| Dec 2028 | $3.50 | $2.50 | $4.13 | 5 | ↑0 ↓0 |
| Dec 2029 | $3.18 | $2.23 | $4.13 | 2 | ↑0 ↓0 |